获取欧盟授权的无偿抗癌药物:荷兰医疗瘤学家的探索性调查
H Colinda Post1, Charlotte H C Bomhof2, Maartje Schermer2
1Department of Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands; Platform ``Medicijn voor de Maatschappij'' (Medicine For Society), Amsterdam, the Netherlands.
Clinical therapeutics
|July 27, 2025
概括
荷兰的瘤学家经常寻求获得无偿的抗癌药物,面临着不同的医院政策和道德问题. 建议制定国家法规,以确保患者平等获得这些必需药物.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 生物伦理学生物伦理学
背景情况:
- 针对抗癌药物的市场授权和补偿时间表在欧洲各国有很大差异.
- 这种差异给医疗瘤学家带来了伦理上的挑战,特别是在公共资助的医疗保健系统中,患者平等地获得创新疗法.
研究的目的:
- 调查荷兰医疗瘤学家关于获得欧盟授权,无偿的抗癌药物的经验和道德观点.
- 评估实践中的差异,并确定瘤学家在提供这些治疗方法方面所面临的挑战.
主要方法:
- 一项调查分发给所有医院的378名荷兰医疗瘤学家.
- 该调查探讨了他们的经验,责任的观点,医院政策,以及对未偿还的抗癌药物的自付费的意见.
主要成果:
- 超过78%的接受调查的瘤学家寻求为患者获得无偿药物,通常是通过"免费"计划或临床试验.
- 报告说,医院政策和瘤学家责任感的显著差异,许多人担心财务毒性和获取不平等.
- 虽然许多患者询问了自付费,但很少有瘤学家开出这种治疗方法,而且不到一半的患者被告知了无偿付款的选择.
结论:
- 大多数荷兰医疗瘤学家都会遇到无偿的抗癌药物,实践和道德观点差异很大.
- 目前缺乏国家准入框架导致医生依赖的可用性和潜在的不平等.
- 国家监管对于为所有患者建立一致和公平的抗癌药物准入至关重要.
更多相关视频
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Nursing Ethical Principles II
1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514


